BESPAK HC LIMITED
Operating as a subsidiary of Bespak Limited, the company manufactures basic pharmaceutical products from its facility in Holmes Chapel, Cheshire.
Get an alert when BESPAK HC LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£117m
+52.2% highest in 3 filed years
Employees
426
+27.5% vs 2024
Profit before tax
£38m
+49% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £86,348,000 | £93,268,000 | £86,923,000 | -6.8% | |
| Operating profit | £16,879,000 | £24,638,000 | £33,915,000 | +37.7% | |
| Profit before tax | £16,309,000 | £25,250,000 | £37,622,000 | +49% | |
| Net profit | £12,008,000 | £18,191,000 | £30,444,000 | +67.4% | |
| Cash | £603,000 | £429,000 | — | — | |
| Total assets less current liabilities | £55,063,000 | £103,836,000 | £170,566,000 | +64.3% | |
| Net assets | £41,778,000 | £77,020,000 | £117,189,000 | +52.2% | |
| Equity | £41,778,000 | £77,020,000 | £117,189,000 | +52.2% | |
| Average employees | 460 | 334 | 426 | +27.5% | |
| Wages | £26,153,000 | £22,920,000 | £19,300,000 | -15.8% | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 19.5% | 26.4% | 39.0% | |
| Net margin | 13.9% | 19.5% | 35.0% | |
| Return on capital employed | 30.7% | 23.7% | 19.9% | |
| Gearing (liabilities / total assets) | 58.2% | 45.8% | 41.7% | |
| Current ratio | 1.16x | 1.55x | 3.06x | |
| Interest cover | 20.19x | 50.59x | 90.20x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- BESPAK HC LIMITED 2024-03-28 → present
- RECIPHARM HC LIMITED 2018-05-03 → 2024-03-28
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst and Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The company is part of a cash pooling arrangement with its immediate parent, Bespak Limited. It is forecast to be cash generative and in a net receivable position at 30 June 2027. A letter of support from Bespak Limited confirms cash pooling and support if needed. Directors are confident funds are sufficient.”
Significant events
- “The Company made charitable donations of £7,000 during the period (2024: £3,000), supporting various community initiatives.”
- “During the year, strategic investments were approved at the Holmes Chapel site to support customers transitioning to low-global warming potential (GWP) propellants, reinforcing Bespak's commitment to sustainable customer solutions.”
- “The Board approved capital investments in new filling technologies and processes to support greener pMDI products, including those using HFA-152a and HFO-1234ze propellants.”
- “The Company also released its inaugural ESG update on 5th June 2025 which can be located on the Company website.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HIRST, Christopher Anthony | Director | 2022-11-01 | Apr 1977 | British |
| HODKINSON, Darren | Director | 2024-04-01 | Jan 1973 | British |
| KLUG, Oren | Director | 2022-02-24 | Sep 1984 | British |
| NEEVE, Maria Louise | Director | 2024-10-07 | May 1974 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAWSON, Andrew Robert Anthony | Director | 2023-02-01 | 2024-04-01 |
| EL-HAGE, Tarik | Director | 2025-01-20 | 2026-02-06 |
| ELDERED, Thomas Bengt | Director | 2018-05-03 | 2021-04-08 |
| HILLAIRE, Jean-Francois | Director | 2021-04-08 | 2022-11-01 |
| HIRST, Peter | Director | 2024-04-01 | 2025-04-17 |
| LODGE, Lisa | Director | 2022-05-06 | 2023-02-01 |
| QUICK, Mark Royston | Director | 2018-05-03 | 2022-02-24 |
| ROBERTS, Claire | Director | 2022-05-06 | 2023-07-31 |
| TIDMARSH, Jeremy David | Director | 2023-10-12 | 2025-02-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bespak Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-04-01 | Active |
| Recipharm Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-05-03 | Ceased 2024-04-01 |
Filing timeline
Last 20 of 55 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-06 | AA | accounts | Accounts with accounts type full | |
| 2026-08-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-07-16 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-05-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-03 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-26 | AP01 | officers | Appoint person director company with name date | |
| 2025-08-22 | AA | accounts | Accounts with accounts type full | |
| 2025-05-17 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-16 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-08 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-10-21 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-08-12 | AA | accounts | Accounts with accounts type full | |
| 2024-05-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-04-23 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-04-23 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-04-12 | SH01 | capital | Capital allotment shares | |
| 2024-04-11 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-10 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.